These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21103385)

  • 1. Patient Cost-Sharing and Hospitalization Offsets in the Elderly.
    Chandra A; Gruber J; McKnight R
    Am Econ Rev; 2010 Mar; 100(1):193-213. PubMed ID: 21103385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare: looking for pareto optimal changes.
    Christensen S
    Inquiry; 1992; 29(4):426-39. PubMed ID: 1473866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
    Demchak C
    Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should you switch Medicare plans?
    Consum Rep; 2004 Sep; 69(9):51. PubMed ID: 15305428
    [No Abstract]   [Full Text] [Related]  

  • 6. What you need to know about Medicare Part D.
    Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
    [No Abstract]   [Full Text] [Related]  

  • 7. Small Changes or Big Ones? The Case of Limits on Prescription Drug Copayments in California.
    Pyenson B; Dieguez G; Simon K; Bochner A
    Manag Care; 2018 Jul; 27(7):27-29. PubMed ID: 29989898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medigap: prevalence, premiums, and opportunities for reform.
    Super N
    NHPF Issue Brief; 2002 Sep; (782):1-23. PubMed ID: 12240698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members.
    Johnson RE; Goodman MJ; Hornbrook MC; Eldredge MB
    Med Care; 1997 Nov; 35(11):1119-31. PubMed ID: 9366891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare: the basics.
    Goldberg E
    Pa Nurse; 2006 Jun; 61(2):11. PubMed ID: 16871978
    [No Abstract]   [Full Text] [Related]  

  • 12. The case against excessive cost sharing.
    Brixner DI
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S162-4; discussion S167-72; quiz S173-6. PubMed ID: 16613531
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent proposals to limit Medigap coverage and modify Medicare cost sharing.
    Linehan K
    Issue Brief George Wash Univ Natl Health Policy Forum; 2012 Feb; (845):1-19. PubMed ID: 22420066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of increasing the coinsurance rate on outpatient utilization of healthcare services in South Korea.
    Lee HJ; Jang SI; Park EC
    BMC Health Serv Res; 2017 Feb; 17(1):152. PubMed ID: 28219377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare supplemental insurance (Medigap).
    Stein N
    Issue Brief Cent Medicare Educ; 2003; 4(6):1-6. PubMed ID: 14503483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D.
    Duggan M; Healy P; Morton FS
    J Econ Perspect; 2008; 22(4):69-92. PubMed ID: 19768843
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare, Medicaid, and the elderly poor.
    Rowland D; Lyons B
    Health Care Financ Rev; 1996; 18(2):61-85. PubMed ID: 10167860
    [No Abstract]   [Full Text] [Related]  

  • 19. Variations in county-level costs between traditional medicare and medicare advantage have implications for premium support.
    Biles B; Casillas G; Guterman S
    Health Aff (Millwood); 2015 Jan; 34(1):56-63. PubMed ID: 25561644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.